Sign in or Register   Sign in or Register
  |  

Mouse Anti-CWF19L1 Recombinant Antibody (CBXC-1783) (CBMAB-C5440-CQ)

This product is a mouse antibody that recognizes CWF19L1. The antibody CBXC-1783 can be used for immunoassay techniques such as: WB, IP, IF, ELISA.
See all CWF19L1 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBXC-1783
Antibody Isotype
IgG
Application
WB, IP, IF, ELISA

Basic Information

Specificity
Human
Antibody Isotype
IgG
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
CWF19 Like 1, Cell Cycle Control (S. Pombe)
Introduction
CWF19L1 (CWF19 Like 1, Cell Cycle Control (S. Pombe)) is a Protein Coding gene. Diseases associated with CWF19L1 include Spinocerebellar Ataxia, Autosomal Recessive 17 and Autosomal Recessive Cerebellar Ataxia. An important paralog of this gene is CWF19L2.
Entrez Gene ID
UniProt ID
Alternative Names
CWF19 Like 1, Cell Cycle Control (S. Pombe); C19L1; CWF19-Like 1 Cell Cycle Control; CWF19-Like Protein 1; SCAR17; HDrn1;
Biological Process
mRNA splicing, via spliceosome Source: GO_Central
Cellular Location
Post-mRNA release spliceosomal complex
Involvement in disease
Spinocerebellar ataxia, autosomal recessive, 17 (SCAR17):
The disease is caused by variants affecting the gene represented in this entry. A disease-causing mutation has been reported that affects an intronic splice donor site and causes exon 9 skipping, this leads to an out-of-frame stop codon after 60 aberrant amino acids. Patients carrying this mutation exhibit much lower mRNA and protein levels compared to unaffected controls, probably due to mRNA nonsense-mediated decay (PubMed:25361784).
A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR17 features include non-progressive congenital cerebellar ataxia, mildly delayed walking with an unsteady gait and frequent falls, dysarthria, dysmetria, hypotonia in the extremities, truncal ataxia, increased reflexes in the lower extremities, and intellectual disability.
Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-CWF19L1 Recombinant Antibody (CBXC-1783)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare